Beta-actin Monoclonal Antibody (Ascites) Blocking peptide
Selected Variant
GTR18976965
Size: 500 µg
Beta-actin Monoclonal Antibody (Ascites) Blocking peptide
Product Specifications
Field of Research
Cancer Biology; Musculoskeletal & Connective Tissue Research
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Ascites region of human Beta-actin Monoclonal. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB1497-100 1x 100 µL
CD20 / MS4A1 (B-Cell Marker) (IGEL/1497R), 0.2mg/mL
Sign In for Pricing
View Details 
BNCB1821-100 1x 100 µL
Langerin / CD207 (Marker of Langerhans Cells) (LGRN/1821), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details